Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days

Trial Profile

Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin
  • Indications Alzheimer's disease; Mild cognitive impairment
  • Focus Pharmacodynamics
  • Acronyms SL120
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Nov 2016 Planned End Date changed from 1 Sep 2015 to 1 Mar 2017.
    • 30 Nov 2016 Planned primary completion date changed from 1 Sep 2015 to 1 Mar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top